Coinhibitory PD-1/PD-L1 (B7-H1) interactions provide critical signals for the regulation of autoreactive T-cell responses. We established mouse models, expressing the costimulator molecule B7.1 (CD80) on pancreatic beta cells (RIP-B7.1 tg mice) or are deficient in coinhibitory PD-L1 or PD-1 molecules (PD-L1 2/2 and PD-1 2/2 mice), to study induction of preproinsulin (ppins)-specific CD8 T-cell responses and experimental autoimmune diabetes (EAD) by DNA-based immunization. RIP-B7.1 tg mice allowed us to identify two CD8 T-cell specificities: pCI/ppins DNA exclusively induced K b /A 12-21 -specific CD8 Tcells and EAD, whereas pCI/ppinsDA [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] 
Introduction
Type 1 diabetes (T1D) is an autoimmune disorder, in which insulin-producing beta cells are destroyed by the cellular immune system [1, 2, 3] . Diabetes development is characterized by progressive infiltration of T-cells into the pancreatic islets and beta cell destruction, resulting in severe hyperglycemia. Disease in man is triggered by poorly defined antigens and factors that finally result in the breakdown of central and/or peripheral tolerance and activation of autoreactive CD4
+ and/or CD8 + T-cells [1, 4] . There is increasing evidence from patients with T1D that autoreactive CD8 + T-cells are involved in the development of disease but it is difficult to detect these rare lymphocytes and to assign their individual effects during the progression of diabetes [5, 6, 7] . It is assumed that the nature of an autoantigen-derived peptide and its presentation by MHC class I molecules plays a central role in the development of T-cell-mediated autoimmunity [8] . In the NOD mouse model [9] , the binding of insulin-derived self peptides to MHC class I or class II molecules is weak and caused by unfavoured binding registers [10, 11, 12] . This suggests that nonconventional antigenic epitope processing and presentation may contribute to the induction of autoreactive immune responses [7, 13] .
Spontaneous diabetes development in the NOD mouse model elucidated many aspects of diabetogenic immune responses [9] . Furthermore, different mouse models have been used to characterize de novo induction of well-defined T-cell responses and their pathogenic cross-talk with beta cells, which selectively express transgene-encoded 'neo-self' antigens under rat insulin promoter (RIP) control [14] . We used transgenic (tg) RIP-B7.1 mice, expressing the costimulatory molecule B7.1 (CD80) on pancreatic beta cells [15] , to characterize induction of preproinsulin (ppins)-specific CD8 T-cells and experimental autoimmune diabetes (EAD) by DNA-based immunization [16, 17, 18, 19] . A single injection of ppins-encoding DNA (pCI/ppins) efficiently induced CD8 T-cell-mediated EAD in both, male and female RIP-B7.1 tg mice with a median onset of 2-3 weeks post immunization and a cumulative diabetes incidence of .95% by week 4 [17] . In these mice, progressive invasion of insulin A-chain-derived K b /A 12-21 -specific CD8 T-cells into pancreatic islets precedes hyperglycemia and insulin deficiency. K b /A 12-21 -specific CD8 T-cells and EAD were efficiently induced by pCI/ppins in MHC class II-deficient (Aa 2/2 ) RIP-B7.1 mice (RIP-B7.1 + /MHC-II 2/2 ) with no conventional CD4 T-cells and in RIP-B7.1 tg mice acutely depleted of CD4 T-cells with anti CD4 antibody [17, 18] . The RIP-B7.1 tg model hence provides an attractive experimental approach to study CD4 T-cell-independent induction of EAD by ppins-specific CD8 T-cells.
We further investigated the impact of coinhibitory 'programmed death-1' (PD-1)/'programmed death-ligand-1' (PD-L1 or B7-H1) molecules on the pathogenicity of ppins-specific CD8 T-cells [19] . PD-1/PD-L1 interactions provide critical inhibitory signals to T-cell responses [20, 21, 22] and facilitate establishment of self-tolerance in NOD mice [23, 24, 25, 26] . There is also evidence from human T1D patients that polymorphic PD-1 gene variations are associated with the susceptibility to disease [27, 28] . Immunization with pCI/ppins DNA efficiently primed K b /A 12-21 -specific CD8 T-cells and EAD in coinhibiton-deficient PD-L1
2/2
and PD-1 2/2 mice [19] . K b /A 12-21 -specific CD8 T-cells were also primed in wild type (wt) C57BL/6 (B6) mice but these cells revealed their diabetogenic potential only after treatment with anti PD-L1 antibody [19] . Furthermore, a deficiency of either PD-L1 in antigen presenting beta cells or PD-1 in T-cells was required to induce K b /A 12-21 -mediated EAD in bone marrow chimeric mice [19] . This suggested that PD-1/PD-L1-mediated signals regulate beta cell-destruction by K b /A 12-21 -specific CD8 T-cells. During the course of EAD in RIP-B7.1 tg mice ex vivo stimulation of ppins-primed CD8 T-cells with the K b /A 12-21 peptide, but not with all other peptides of a ppins-specific library, revealed a CD8 T-cell population with specifically inducible IFNc expression [19] . This suggested that the K b /A 12-21 is the only diabetogenic epitope in ppins-immune RIP-B7.1 tg mice. However, a mutant ppinsDA [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] antigen (with a deletion of the COOH-terminal A 12-21 sequence) also induced CD8 T-cellmediated EAD in RIP-B7.1 tg mice, indicating that EAD can be induced by CD8 T-cell responses that have specificities other than K b /A 12-21 [18] . In this study, we mapped the alternative CD8 Tcell epitope in pCI/ppinsDA 12-21 -immune RIP-B7.1 tg mice and investigated the antigen expression and processing requirements to prime this CD8 T-cell specificity and EAD. We further used coinhibiton-deficient PD-1 2/2 , PD-L1 2/2 and RIP-B7.1 + /PD-L1 2/2 mice (differing from PD-L1 2/2 mice only in the tg B7.1 expression in beta cells) to determine whether induction of ppinsand ppinsDA [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] -specific CD8 T-cell responses and diabetes development depends on specific costimulatory and coinhibitory signals from pancreatic beta cells.
Materials and Methods

Ethics Statement
All mouse immunization studies were carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the German Federal Animal Protection Law. The protocols were approved by the Committee on the Ethics of Animal Experiments of the University of Ulm (Tierforschungszentrum Ulm, Oberberghof) and the Regierungsprä sidium Tübingen (Permit Numbers: 897 and 1105 to RS). All immunizations were performed under short time Isofluran anesthesia, and all efforts were made to minimize suffering.
Mice RIP-B7.1 mice were backcrossed for .15 generations to the C57BL/6 (H-2 b ) background as described [15] . 
Construction of Expression Plasmids
The sequences of the different ppins antigens were codonoptimized and synthesized by GeneArt (Regensburg, Germany). All constructs were cloned into the pCI vector (cat.no. E1731, Promega, Mannheim, Germany) using the NheI and NotI restriction sites. Batches of plasmid DNA were produced in E. coli by PlasmidFactory GmbH (Bielefeld, Germany).
Characterization of Antigen Expression
Human embryonal kidney cells (HEK-293 cells) were transiently transfected with the indicated plasmid DNAs using the calcium phosphate method. Cells were labeled with 100 mCi 35 S-methionine/cysteine (cat. no. IS103, Hartmann Analytic GmbH) between 36 and 48 h post transfection and subsequently lysed with pH 8.0 lysis buffer (100 mM NaCl, 0.5% NP40 and 100 mM Tris-hydrochloride) supplemented with the protease inhibitors, leupeptin and aprotinin. Extracts were cleared by centrifugation and precipitated with polyclonal rabbit H-86 anti-insulin (cat. no. sc-9168, Santa Cruz Biotechnology) and protein G sepharose. Precipitates were processed for SDS-PAGE (15%) and subsequent fluorography of the gels. Alternatively, non-labeled cells were lysed in a SDS-containing buffer (3% SDS, 50 mM Tris-hydrochloride, 5% b-mercaptoethanol) and, for high resolution of protein bands, samples were directly loaded onto urea-containing SDS-polyacrylamide gels (16%) [32] . Gels were blotted onto a nitrocellulose membrane using the iBlotH Dry Blotting System (cat. no. IB3010-01; Invitrogen, Carlsbad, CA, USA). Membranes were blocked for 20 min at RT in a buffer supplemented with 0.1% Tween 20, 0.1% gelatine and 3% milk powder, followed by successive incubations with rabbit H-86 anti-insulin antibody and HRPconjugated anti rabbit IgG (cat. No. NA9340; GE Healthcare, Chalfont St Giles, UK). Specific protein bands were detected using the Immobilon TM Western Chemoluminescent HRP substrate (cat. No. WBKLS0100; Millipore, Bedford, MA, USA) followed by subsequent exposure of the membranes to an Amersham Hyperfilm ECL (cat. No. 92004; GE Healthcare).
Immunization of Mice
Plasmid DNA (75-100 mg/mouse) dissolved in PBS was injected into both tibialis anterior muscles. Diabetes was diagnosed if two consecutive blood glucose values (within 2 days) exceeded 250 mg/dl, i.e. 13.8 mmol/l (Disetronic Freestyle, Sulzbach, Germany).
Histology
H&E staining and immunohistochemistry of pancreatic sections was performed as described previously [16] 
Isolation of CD8 T-cells from Pancreatic Tissues
Pancreata were perfused in situ with collagenase P (cat. no. 11213865001, Roche) dissolved at 1 mg/ml in Hanks Balanced Salt Solution (HBSS), removed, digested again with collagenase P for 8 min at 37uC and washed twice with cold HBSS supplemented with 10% FCS. Pancreatic cells were purified with Histopaque-1077 (cat. no. 10771, Sigma-Aldrich) by centrifugation for 15 min at 2400 rpm.
Determination of Specific CD8 T-cell Frequencies
To detect ppins-specific CD8 T-cell responses, we used a ppinsspecific peptide library (i.e. 10mers with two amino acids offset) (JPT Peptide Technologies, Berlin, Germany). Peptides were dissolved in DMSO at a concentration of 10 mg/ml and diluted with culture medium prior to use. Pancreatic cells (10 5 /100 ml) were incubated for 16 h in Ultra Culture medium (cat. no.BE 12-725F, Lonza, Belgium) containing 10 mg/ml of the indicated peptides in the presence of brefeldin A (0.5 mg/ml) (cat. no. 15870; Sigma, Taufkirchen, Germany). Cells were harvested, surface stained with APC-conjugated anti CD8 antibody (cat. no. 17-0081-83, BD Biosciences, Heidelberg, Germany), fixed with 2% paraformaldehyde, resuspended in permeabilization buffer (HBSS, 0.5% BSA, 0.5% saponin, 0.05% sodium azide), and stained with FITC-conjugated anti-IFNc antibody (cat. no.554411; BD Biosciences, Heidelberg, Germany). Non-specific binding of antibodies to Fc-receptor was blocked by preincubating cells with mAb 2.4G2 (cat. no. 01241D; BD Biosciences, Heidelberg, Germany) directed against the FccRIII/II CD16/CD32 (0.5 mg mAb/10 6 cells/ 100 ml). Frequencies of IFNc + CD8 T-cells were determined by flow cytometry (FCM) using a BD LSR-II Flow Cytometer.
Furthermore, specific CD8 T-cells were analyzed with K b /B 22-29 tetramers (Glycotope, Heidelberg, Germany). Freshly isolated cells were washed twice in PBS/0.3% w/v BSA/0.1% w/v sodium azide. Non-specific binding of antibodies to Fc-receptor was blocked by preincubating cells with mAb 2.4G2 as described above. Cells were incubated for 30 min at 4uC with FITC-labeled anti-CD8 mAb (BD Biosciences, Heidelberg, Germany) and PEor APC-conjugated tetramers. Cells were washed and analyzed by FCM.
Statistics
The statistical significance of differences in the mean CD8 Tcell frequencies between groups was determined by the unpaired student's t-test. The statistical significance of diabetes induction in immunized mice was determined by the log-rank test. Data were analyzed using PRISM software (GraphPad, San Diego, CA). Values of P,0.05 were considered significant.
Results
Induction of Distinct ppins-specific CD8 T-cells is Critically Dependent on the Antigen Used
A single injection of pCI/ppins plasmid DNA ( Figure 1A ) efficiently induced CD8 T-cell-mediated EAD in RIP-B7.1 tg mice ( Figure 1B and C) [19] . CD8 T-cells isolated from pancreata of ppins-primed, diabetic RIP-B7.1 tg mice recognized the K brestricted A 12-21 (i.e., ppins 101-110 ) epitope of ppins and, with a better efficacy, an epitope variant (A 12-N21A ) with an alanine (A) exchange for the COOH-terminal asparagine (N) at position A 21 ( Figure 1A ) [19] . Similarly, a pCI/ppinsDA 12-21 DNA (encoding a truncated ppins protein without the COOH-terminal K b /A 12-21 epitope; Figure 1A ) also induced severe hyperglycemia and diabetes in RIP-B7.1 tg mice ( Figure 1B and C) [18] . The kinetics and diabetes incidences were comparable in pCI/ppins-and pCI/ ppinsDA 12-21 -immune RIP-B7.1 tg mice ( Figure 1B and C).
CD8 T-cells isolated from pancreata of pCI/ppinsDA 12-21 -primed and diabetic RIP-B7.1 tg mice specifically recognized the overlapping ppins [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] and ppins [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] peptides of a ppins library (i.e., 10 mers with two amino acids offset; Figure 1D ). These sequences contain an optimal K b -binding motif, i.e., Y at anchor position P5 and M at anchor position P8 [33] . Ex vivo restimulation of CD8 T-cells with this antigenic ppins [46] [47] [48] [49] [50] [51] [52] [53] (B 22-29 ) peptide revealed a CD8 T-cell population with specifically inducible IFNc expression in pCI/ppinsDA 12-21 -(but not in pCI/ppins-) immune and diabetic RIP-B7.1 tg mice ( Figure 1E , groups 2 and 3; Table  S1 ). We could exclude that a simple immune competition between Table S1 ). Hence, after successful priming, the two CD8 Tcell populations do not interfere with each another. Furthermore, immunization of MHC class II-deficient (Aa 2/2 ) RIP-B7.1 tg mice (RIP-B7.1 + /MHC-II 2/2 ) with pCI/ppins [18] and pCI/ ppinsDA [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] Figure 3A ), inefficiently induced late EAD in one out of eight RIP-B7.1 tg mice ( Figure 3B, group 2) . Similarly, a pCI/SP-B-C construct (encoding the ER-targeting signal peptide up to the C-peptide; Figure 3A ) did not induce EAD in RIP-B7.1 tg mice within three months post immunization ( Figure 3B, group 3) . We thus conclude that efficient priming of K b /B 22-29 -reactive CD8 Tcells by pCI/ppinsDA [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] critically depends on specific properties of the mutant antigen itself.
We next characterized the expression of mutant ppinsDA 12-21 and ppins in transiently transfected HEK-293 cells ( Figure 3C and D). In these non-beta cells, the ppins signal peptide (SP) targets the proteins into the ER, where the SP is removed to generate proinsulin (pins) or pinsDA [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] but further downstream processing of pins to insulin was not detectable [17;36] . The expression levels of 35 S-methionine/cysteine labeled pinsDA [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] were weaker than that of pins ( Figure 3C, lanes 2 and 3) and significant steadystate levels of pins (but not of mutant pinsDA [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] ) were detectable by specific western blot analyses ( Figure 3D, lanes 1 and 2) . [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] (groups 3, n = 6). At indicated times after immunization, blood glucose levels (B) and cumulative diabetes incidences (C) were determined. The statistical significance of diabetes induction in immunized mice was determined using the log-rank test. Values of P,0.05 were considered significant. (D) CD8 T-cells were prepared from pancreata of pCI/ppinsDA 12-21 -immune and diabetic RIP-B7.1 tg mice. Pancreatic cell preparations from ten mice were pooled and restimulated ex vivo for 16 hours with a ppins-specific peptide library (i.e., 10 mers with two amino acids offset) and frequencies of IFNc + CD8 T-cells were determined by by flow cytometry (FCM). The mean % of IFNc + CD8 T-cells in the pancreatic CD8 T-cell population (obtained from two independent experiments) are shown. CD8 T-cell frequencies ,0.05% are defined negative. (E) RIP-B7.1 tg mice were immunized with pCI (group 1), pCI/ppins (group 2), pCI/ppinsDA 12-21 (group 3) or pCI/ppins and pCI/ppinsDA [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] (group 4). In group 4, the indicated plasmids were injected into the right and the left tibialis anterior muscles, respectively. CD8 T-cells were prepared from pancreata of diabetic (groups 2-4) or non-diabetic (group 1) mice and restimulated ex vivo with A 12-N21A or B 22-29 peptides. Specific IFNc + CD8 T-cell frequencies were determined by FCM. The mean % of IFNc + CD8 T-cells in the pancreatic CD8 T-cell population (6SD) of a representative experiment (n = 3 mice per group) is shown. The statistical significance of differences between A 12-N21A -(groups 2 and 4) and K b /B 22-29 -specific CD8 T-cell frequencies (groups 3 and 4) was determined by the unpaired Student's t-test (ns, not significant). doi:10.1371/journal.pone.0071746.g001 CD8 T-Cell-Mediated Induction of Diabetes PLOS ONE | www.plosone.orgHowever, treatment of transfectants with the proteasome inhibitors epoxomicin or lactacystin efficiently restored pinsDA 12-21 levels within 6 hours ( Figure 3D, lanes 2 to 4) . This showed that the pinsDA [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] is efficiently processed by proteasomal degradation. In contrast, the expression of ppins in transiently transfected HEK-293 cells was not changed by proteasome inhibitors [18] . This implies that proteasomes play an essential role in the pCI/ ppinsDA 12-21 -specific antigen processing/presentation and the induction of K b /B 22-29 specific CD8 T-cells. + CD8 T-cells were determined during the course of pCI/ppinsDA 12-21 -mediated EAD: group 1, health mice (n = 3) with blood glucose levels ,200 mg/dl; group 2, early diabetic mice (n = 3) with blood glucose levels between 250-350 mg/dl; group 3, diabetic mice (n = 3) with severe diabetes (i.e., blood glucose levels between 400-550 mg/dl). Pancreata of representative mice out of groups 1 to 3 were analyzed histologically for CD8 T-cell influx (CD8+) or stained with hematoxylin-eosin (H&E). doi:10.1371/journal.pone.0071746.g002 4) . At 28 h after transfection, cells were either non-treated (lanes 1 and 2) , or incubated for 6 h with the proteasome-inhibitors expoxymycin (ep; lane 3) or lactacystein (lac; lane 4) and subsequently lysed. Total cell extracts were subjected to high resolution tricine-urea-SDS-PAGE (16%) followed by anti-insulin (H86) specific western blotting. Table S1 ). We could not induce EAD in PD-L1 [19] but not pCI/ppinsDA [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] ( Figure S3 ). (Table S1 ) [19] . [38, 39, 40] . These events play a prominent role in the amplification of autoreactive immune responses and beta cell destruction [38, 39, 40] . We thought that an initial isletdestructive K b /A 12-21 -specific CD8 T-cell response (primed in PD-L1 2/2 mice by pCI/ppins) could facilitate the expansion of pCI/ppinsDA 12-21 -coprimed K b /B 22-29 -specific CD8 T-cells. To test this assumption, we co-immunized PD-L1 2/2 mice with both, pCI/ppins and pCI/ppinsDA [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] vectors (pCI/ppins+pCI/ ppinsDA [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] ) into the left and right tibialis anterior muscles, respectively. These mice efficiently developed an early and severe EAD ( Figure 4C, mice (see Figure 4A ; data not shown). In these mice, we found a significant influx of CD8 T-cells ( Figure S2B ) and other bystander cells (e.g., CD4 T-cells, macrophages, DCs) into or closely attached to the pancreatic islets of early diabetic PD-L1 2/2 mice ( Figure 5 ). The inflammatory islet invasion by these cell populations was comparable in pCI/ppins-and pCI/ ppins+pCI/ppinsDA 12-21 -immune and diabetic (but not in pCI/ ppinsDA 12-21 -immune and healthy) PD-L1 
Discussion
We continued work on the specific priming of ppins-specific CD8 T-cells and EAD in RIP-B7.1 tg mice [16, 17, 18, 19] . DNAbased immunization of RIP-B7.1 tg mice revealed two monospecific CD8 T-cell responses that were exclusively induced by either pCI/ppins (primes K b /A 12-21 -specific CD8 T-cells) or pCI/ ppinsDA [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [25, 41] . Interestingly, expression of PD-L1 has no impact on the priming of K b /A 12-21 -specific CD8 T-cells in PD-L1-competent wt B6 mice. However, ppins-immune B6 mice rapidly developed EAD after treatment with anti PD-L1 antibody [19] . This suggested that PD-L1-mediated signals delivered by pancreatic beta cells are sufficient to regulate their susceptibility for the destructive K b /A 12-21 -specific CD8 T-cell attack [19] . We found no evidence for an autoreactive immune response in pCI/ppinsDA [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . It is thus unlikely that the initial CD8 T-cell priming phase (i.e., intramuscular injection of pCI/ppinsDA 12-21 DNA; 
/CD28
2/2 mice do not develop EAD after immunization with pCI/ppins [19] or pCI/ppinsDA [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] (data not shown). The interaction of B7.1 on the surface of beta cells with CD28 costimulator molecules on CD8 T-cells may thus promote T-cell-driven EAD in RIP-B7.1 tg mice by facilitating effector function delivery but a critical effect of CD28 in CD8 Tcell priming can not be excluded.
We here identified an alternative mechanism to promote the expansion and influx of diabetogenic K b /B 22-29 -specific CD8 Tcells into the pancreata of pCI/ppinsDA [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [38, 39, 40] . An initial beta cell death and antigen release could facilitate activation of circulating, pCI/ppinsDA 12-21 -preprimed K b /B 22-29 -specific CD8 T-cells in the regional lymph nodes by professional APCs [42] . Furthermore, an altered local cytokine milieu and expression of cell surface receptors [40] or an enhanced antigen presentation by beta cells [43] [10, 44, 45] . Prasad et al. previously showed that an initial insulin B9-23-specific T-cell response is immunodominant and autoimmune responses to epitope(s) distinct from B9-23 emerge during the pathogenic progression of diabetes in NOD mice [46] . Similarly, CD8 T-cells specific for the islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP) were detected in NOD mice but not in tg NOD mice tolerant to proinsulin, indicating that an initial T-cell response against proinsulin is necessary for the development of IGRP-specific CD8 T-cells [47] . This suggests that distinct CD8 T-cell responses, triggering the initial steps of beta cell destruction, play a prime role in the induction of diabetes [44] .
In conclusion, we showed in this study that inhibitory interactions between ppins/insulin-presenting beta cells and autoreactive CD8 T-cells either allow or prevent activation of pathogenic effector responses. 2/2 mice were immunized with pCI (group 1, n = 3), pCI/ppins (group 2, n = 6) or pCI/ppinsDA [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] (group 3, n = 12) and cumulative diabetes incidences (%) were determined. (EPS) 
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